{
    "eid": "2-s2.0-85150914151",
    "title": "The reliability of FEbrile Neutropenia after ChEmotherapy (FENCE) scores in predicting granulocyte colony-stimulating factor breakthrough febrile neutropenia among patients with lymphoma undergoing first-cycle chemotherapy: A prospective observational study",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "adult",
        "cancer",
        "FENCE score",
        "first cycle chemotherapy",
        "lymphoma"
    ],
    "authors": [
        "Pravinwan Thungthong",
        "Supat Chamnanchanunt",
        "Tawatchai Suwanban",
        "Chajchawan Nakhahes",
        "Kunapa Iam-arunthai",
        "Tananchai Akrawikrai",
        "Udomsak Bunworasate",
        "Ponlapat Rojnuckarin"
    ],
    "citedby-count": 0,
    "ref-count": 18,
    "ref-list": [
        "Febrile neutropenia in acute leukemia. Epidemiology, etiology, pathophysiology and treatment mediterr",
        "Real-world comparison of febrile neutropenia rates with same-day versus next-day administration of pegfilgrastim",
        "Systematic review and meta-analysis of short-versus long-acting granulocyte colony-stimulating factors for reduction of chemotherapy-induced febrile neutropenia",
        "Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice",
        "Continuous intravenous administration of granulocyte-colony-stimulating factors\u2014a breakthrough in the treatment of cancer patients with febrile neutropenia",
        "Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)",
        "Development and validation of a risk score for febrile neutropenia after chemotherapy in patients with cancer: the FENCE score",
        "Validation of the FENCE risk groups for prediction of febrile neutropenia with first-cycle chemotherapy",
        "Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: a systematic review",
        "Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non-Hodgkin lymphoma (NADIR study)",
        "Prophylaxis of febrile neutropenia with colony-stimulating factors: the first 25 years",
        "Accuracy of the multinational association of supportive care in cancer (MASCC) and clinical index of stable febrile neutropenia (CISNE) scores for predicting serious complications in adult patients with febrile neutropenia: a systematic review and meta-analysis",
        "Clinical outcomes, treatment toxicity, and health care utilization in older adults with aggressive non-hodgkin lymphoma",
        "Risk assessment in oncology clinical practice. From risk factors to risk models",
        "Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management",
        "The economics of the colony-stimulating factors in the prevention and treatment of febrile neutropenia",
        "Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199573",
            "affilname": "Faculty of Tropical Medicine, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199573",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60023366",
            "affilname": "Rangsit University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Rajavithi Hospital",
        "Thai Society of Hematology",
        "Mahidol University"
    ]
}